Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search
Jun 06 2022

Age Structure Series, June 3

By Kevin Roche Commentary No Comments
The latest in the regular series showing the age distribution of all events during the epidemic.
Read More
Jun 06 2022

Wastewater CV-19 Levels, June 1

By Kevin Roche Commentary No Comments
Not sure what the wastewater analysis is telling us.
Read More
Jun 06 2022

Breakthru Events, 65 and Over

By Kevin Roche Commentary No Comments
The final age group, everyone over age 65, where boosters show continuing benefit.
Read More
Jun 06 2022

Breakthru Events, Ages 50 to 64

By Kevin Roche Commentary No Comments
On to the middle aged group for our breakthrough event analysis.
Read More
Jun 06 2022

Breakthrough Events, Ages 18 to 49

By Kevin Roche Commentary No Comments
On to the 118 to 49 age group, where there appears to be some remaining benefit of vax in preventing hospitalization.
Read More
Jun 06 2022

Breakthrough Events, Ages 12 to 17

By Kevin Roche Commentary No Comments
The next age group for the detailed breakthrough analysis is the 12-17 year-olds.
Read More
Jun 06 2022

Breakthru Events, Ages 5-11

By Kevin Roche Commentary 2 Comments
Breaking the breakthru data into smaller age group posts.
Read More
Jun 05 2022

The Trustees Report on Medicare Funds

By Kevin Roche Commentary One Comment
Medicare covers about a fifth of all Americans and the hospital part of the program has an imminent financing crisis.
Read More
Jun 03 2022

Coronamonomania Lives Forever, Part 142

By Kevin Roche Commentary 4 Comments
Summer blossoms as do our ongoing efforts to keep you up on the research.
Read More
Jun 02 2022

Breakthrough Events, From the Omicron Wave Forward

By Kevin Roche Commentary 4 Comments
During the Omicron wave vaccine performance, including boosters, has steadily trended down, and has basically zero effectiveness in the total population now.
Read More
Jun 02 2022

Breakthrough Events, May 31 Part 1

By Kevin Roche Commentary No Comments
A more accurate picture than DOH's gives is found in Dave Dixon's charts on breakthrough events.
Read More
May 31 2022

Why Do We Have Uvaldes?

By Kevin Roche Commentary 3 Comments
School schootings are symptomatic of our deeply dysfunctional society and in particular our disregard for the welfare of children, all driven by the lunacy of one political party.
Read More
May 30 2022

Coronamonomania Lives Forever, Holiday Edition

By Kevin Roche Commentary 11 Comments
Rainy day here in Minnesota, so why not crank out a few research summaries.
Read More
May 28 2022

Age Structure Charts May 26

By Kevin Roche Commentary No Comments
Another week of age group charts.
Read More
May 27 2022

Coronamonomania Lives Forever, Part 141

By Kevin Roche Commentary No Comments
Another sprinkling of topics for the regular research summaries.
Read More
  • Previous
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 414
  • Next

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

Press Ganey, which provides market research for health plans and providers , is being purchased by health care survey firm Qualtrics for $6.75 billion.  Both companies claim this is all...
October 6, 2025
Another weirdly named company, Thyme Care, spices things up by raising a fresh $97 million in capital to support its cancer care managment business.
September 25, 2025
Sometimes companies change their name, I have no idea why and it often seems goofy.  CapitalRx, which is a pharmacy benefit manager, with aspirations to be a broader technology provider...
September 25, 2025
Innovacer, a health care technology company that claims extensive use of artificial intelligence, is acquiring Story Health, which helps manage patients with chronic care conditions and who need specialty care.
September 18, 2025

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1841) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Health Affairs
  • Congressional Budget Office

RSS Feed

RSS feed

© 2025 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts